Loading
Latest filing published 02 Jul 2024 for bioAffinity Technologies, Inc..
No signal scores available.
Jamie Platt is a declared insider of bioAffinity Technologies, Inc., with filings sourced from SEC (Form 4). The record holds 3 filings, for trades running from 1 January 2024 to 1 July 2024.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 2 July 2024 with a share grant in bioAffinity Technologies, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations